FI941459A0 - Tuumorinekroositekijän muteiineja - Google Patents
Tuumorinekroositekijän muteiinejaInfo
- Publication number
- FI941459A0 FI941459A0 FI941459A FI941459A FI941459A0 FI 941459 A0 FI941459 A0 FI 941459A0 FI 941459 A FI941459 A FI 941459A FI 941459 A FI941459 A FI 941459A FI 941459 A0 FI941459 A0 FI 941459A0
- Authority
- FI
- Finland
- Prior art keywords
- necrosis factor
- tumor necrosis
- muteins
- factor muteins
- tumor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93810224 | 1993-03-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI941459A0 true FI941459A0 (fi) | 1994-03-29 |
FI941459A FI941459A (fi) | 1994-09-30 |
Family
ID=8214942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI941459A FI941459A (fi) | 1993-03-29 | 1994-03-29 | Tuumorinekroositekijän muteiineja |
Country Status (14)
Country | Link |
---|---|
US (1) | US5597899A (fi) |
EP (1) | EP0619372A1 (fi) |
JP (1) | JPH089976A (fi) |
CN (1) | CN1099802A (fi) |
AU (1) | AU5901994A (fi) |
BR (1) | BR9401321A (fi) |
CA (1) | CA2119089A1 (fi) |
CZ (1) | CZ67694A3 (fi) |
FI (1) | FI941459A (fi) |
HU (1) | HUT68218A (fi) |
IL (1) | IL109094A0 (fi) |
NO (1) | NO941142L (fi) |
NZ (1) | NZ260146A (fi) |
RU (1) | RU94009852A (fi) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2253557A1 (en) * | 1996-05-08 | 1997-11-13 | Louis Martin Renzetti | Treatment of asthma with tnfr-ig |
SI0975668T1 (sl) | 1997-04-15 | 2007-02-28 | Pharmexa As | Modificirana molekula TNFalfa, DNA, ki kodira tako modificirano molekulo TNFalfa in cepivo, ki vsebuje tako modificirano molekulo TNFalfa in DNA |
CN1062274C (zh) * | 1997-10-07 | 2001-02-21 | 复旦大学 | 人肿瘤坏死因子α衍生物及其制备方法 |
US6354297B1 (en) * | 1998-04-16 | 2002-03-12 | The Uniformed Services University Of The Health Sciences | Method and device for destroying fat cells by induction of programmed cell death |
US6620382B1 (en) * | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
US8197430B1 (en) * | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
US6379708B1 (en) * | 1999-11-20 | 2002-04-30 | Cytologic, Llc | Method for enhancing immune responses in mammals |
US7687461B2 (en) * | 2000-03-02 | 2010-03-30 | Xencor, Inc. | Treatment of TNF-α related disorders with TNF-α variant proteins |
US7446174B2 (en) | 2001-03-02 | 2008-11-04 | Xencor, Inc. | Protein based TNF-α variants for the treatment of TNF-α related disorders |
US20070172449A1 (en) * | 2000-03-02 | 2007-07-26 | Xencor, Inc. | TNF-alpha VARIANT FORMULATIONS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
US7662367B2 (en) * | 2000-03-02 | 2010-02-16 | Xencor, Inc. | Pharmaceutical compositions for the treatment of TNF-α related disorders |
US7244823B2 (en) * | 2000-03-02 | 2007-07-17 | Xencor | TNF-alpha variants proteins for the treatment of TNF-alpha related disorders |
US7056695B2 (en) | 2000-03-02 | 2006-06-06 | Xencor | TNF-α variants |
US7101974B2 (en) | 2000-03-02 | 2006-09-05 | Xencor | TNF-αvariants |
WO2003057856A2 (en) * | 2002-01-04 | 2003-07-17 | Xencor | Dominant negative proteins and methods thereof |
JP4177604B2 (ja) * | 2002-03-25 | 2008-11-05 | 株式会社林原生物化学研究所 | 生理活性複合体 |
US7179891B2 (en) * | 2002-03-25 | 2007-02-20 | Tadanori Mayumi | Physiologically active complex |
DE60333228D1 (de) * | 2002-12-02 | 2010-08-12 | Amgen Fremont Inc | Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen |
EP1628618A4 (en) * | 2002-12-26 | 2009-09-09 | Mountain View Pharmaceuticals | POLYMER CONJUGATES OF CYTOKINES, CHEMOKINS, GROWTH FACTORS, POLYPEPTIDE HORMONES AND ANTAGONISTS THEREOF WITH PRESERVED RECEPTOR BINDING ACTIVITY |
US7642340B2 (en) * | 2003-03-31 | 2010-01-05 | Xencor, Inc. | PEGylated TNF-α variant proteins |
CA2542353A1 (en) * | 2003-10-10 | 2005-04-21 | Xencor, Inc. | Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
TW200526780A (en) * | 2004-01-06 | 2005-08-16 | Hayashibara Biochem Lab | TNF antagonists and TNF inhibitors comprising the same as the active ingredient |
AU2005240082B2 (en) * | 2004-04-30 | 2009-07-23 | Innatus Corporation | Method and system to remove soluble TNFR1,TNFR2, and IL2 in patients |
GB0425972D0 (en) | 2004-11-25 | 2004-12-29 | Celltech R&D Ltd | Biological products |
US20070065514A1 (en) * | 2005-09-22 | 2007-03-22 | Howell Mark D | Method for enhancing immune responses in mammals |
US20080075690A1 (en) * | 2006-09-22 | 2008-03-27 | Mark Douglas Howell | Method for enhancing immune responses in mammals |
WO2008127515A1 (en) * | 2007-03-01 | 2008-10-23 | Cytologic, Inc. | Compositions and method for enhancing immune responses in mammals |
GB201510758D0 (en) | 2015-06-18 | 2015-08-05 | Ucb Biopharma Sprl | Novel TNFa structure for use in therapy |
CN106540252B (zh) * | 2016-12-07 | 2020-04-28 | 四川大学 | 针对肿瘤坏死因子α的蛋白疫苗及其用途 |
GB201621907D0 (en) | 2016-12-21 | 2017-02-01 | Ucb Biopharma Sprl And Sanofi | Antibody epitope |
JP7370580B2 (ja) * | 2017-04-06 | 2023-10-30 | ウニヴェルズィテート シュトゥットガルト | 結合および生物活性を改善した腫瘍壊死因子受容体(tnfr)結合タンパク質複合体 |
US11957825B2 (en) | 2021-06-17 | 2024-04-16 | Immunicom Inc. | Modified TNF as a capture ligand |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
DE19975063I2 (de) * | 1984-03-06 | 2005-08-18 | Dainippon Pharmaceutical Co | DNS den menschlichen Tumornekrosisfaktor kodierendund das menschliche Tumornekronisfaktor-Polypepti d. |
GR851626B (fi) * | 1984-07-05 | 1985-11-26 | Genentech Inc | |
US4650674A (en) * | 1984-07-05 | 1987-03-17 | Genentech, Inc. | Synergistic cytotoxic composition |
DE3750056T2 (de) * | 1986-06-20 | 1995-04-06 | Dainippon Pharmaceutical Co | Polypeptid-Mutanten des menschlichen TNF und für diese Mutanten codierende DNS. |
JPH07106158B2 (ja) * | 1986-12-04 | 1995-11-15 | サントリー株式会社 | 抗腫瘍活性を有する新規ポリペプチドおよびその製造法 |
AU1346488A (en) * | 1987-02-26 | 1988-09-26 | Cetus Corporation | Arginine-depleted human tumor necrosis factor |
DE3843534A1 (de) * | 1988-12-23 | 1990-07-12 | Basf Ag | Neue tnf-polypeptide |
CA2055168A1 (en) * | 1990-11-21 | 1992-05-22 | Walter Fiers | Tnf-muteins |
IL99120A0 (en) * | 1991-08-07 | 1992-07-15 | Yeda Res & Dev | Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them |
CZ283533B6 (cs) * | 1992-04-02 | 1998-04-15 | F. Hoffmann-La Roche Ag | TNF - muteiny a způsob jejich výroby |
-
1994
- 1994-03-15 CA CA002119089A patent/CA2119089A1/en not_active Abandoned
- 1994-03-17 EP EP94104154A patent/EP0619372A1/en not_active Withdrawn
- 1994-03-22 NZ NZ260146A patent/NZ260146A/en unknown
- 1994-03-23 AU AU59019/94A patent/AU5901994A/en not_active Abandoned
- 1994-03-23 CZ CZ94676A patent/CZ67694A3/cs unknown
- 1994-03-23 IL IL10909494A patent/IL109094A0/xx unknown
- 1994-03-23 HU HU9400829A patent/HUT68218A/hu unknown
- 1994-03-24 US US08/217,529 patent/US5597899A/en not_active Expired - Fee Related
- 1994-03-24 RU RU94009852/13A patent/RU94009852A/ru unknown
- 1994-03-28 CN CN94103792A patent/CN1099802A/zh active Pending
- 1994-03-28 BR BR9401321A patent/BR9401321A/pt not_active Application Discontinuation
- 1994-03-28 NO NO941142A patent/NO941142L/no unknown
- 1994-03-29 JP JP6059514A patent/JPH089976A/ja active Pending
- 1994-03-29 FI FI941459A patent/FI941459A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
BR9401321A (pt) | 1994-10-18 |
AU5901994A (en) | 1994-10-06 |
CA2119089A1 (en) | 1994-09-30 |
FI941459A (fi) | 1994-09-30 |
CN1099802A (zh) | 1995-03-08 |
HUT68218A (en) | 1995-06-28 |
US5597899A (en) | 1997-01-28 |
HU9400829D0 (en) | 1994-06-28 |
JPH089976A (ja) | 1996-01-16 |
NO941142D0 (no) | 1994-03-28 |
IL109094A0 (en) | 1994-06-24 |
CZ67694A3 (en) | 1995-02-15 |
EP0619372A1 (en) | 1994-10-12 |
NZ260146A (en) | 1995-10-26 |
NO941142L (no) | 1994-09-30 |
RU94009852A (ru) | 1996-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI941459A0 (fi) | Tuumorinekroositekijän muteiineja | |
DE69311185D1 (de) | Verbinder | |
DE69304176D1 (de) | Verbinder | |
DE69405782D1 (de) | Verbinder | |
DE69411322D1 (de) | Verbinder | |
DE69402317D1 (de) | Orientierer | |
DE69512024D1 (de) | Polyedrische richtwandleranordnung | |
GB2275683B (en) | Tumor necrosis factor muteins | |
DE69408554D1 (de) | Verbinder | |
DE69429752D1 (de) | Drosselspule | |
DE69315043D1 (de) | Verbinder | |
DE69420234D1 (de) | Verbinder | |
KR930702896A (ko) | 종양괴사인자 억제제 | |
DE69413911D1 (de) | Verbinder | |
DE69310773D1 (de) | Verbinder | |
DK0672234T3 (da) | Frysetørringsanlæg | |
DE69301589D1 (de) | Verbinder | |
DE69311024D1 (de) | Verbinder | |
FI931541A0 (fi) | Dirigerande konisk ljusanordning | |
KR950010872U (ko) | 서책식 화장지 | |
ES1026683Y (es) | Farol perfeccionado | |
ATA114394A (de) | Kochfeld | |
KR950000008U (ko) | 마늘 수확기 | |
ITRG920007V0 (it) | Calciomercato | |
KR940025876U (ko) | 해태구이기 |